Cargando…
Effectiveness of Favipiravir monotherapy in the treatment of COVID-19: real world data analysis from Thailand
BACKGROUND: Previous studies showed that Favipiravir, a selective viral ribonucleic acid dependent-ribonucleic acid polymerase inhibitor, exhibited a trend of clinical improvement within 14 days and promoted viral clearance by day 7, without reduction of mortality rate in COVID-19. METHODS: During t...
Autores principales: | Srisubat, Attasit, Thanasitthichai, Somchai, Kongsaengdao, Subsai, Maneeton, Narong, Maneeton, Benchalak, Akksilp, Somsak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902286/ https://www.ncbi.nlm.nih.gov/pubmed/36776761 http://dx.doi.org/10.1016/j.lansea.2023.100166 |
Ejemplares similares
-
Quality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective study
por: Kongsaengdao, Subsai, et al.
Publicado: (2017) -
Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study
por: Kongsaengdao, Subsai, et al.
Publicado: (2018) -
The Five-Year Prospective Study of Quality of Life in Hemifacial Spasm Treated with Abo-Botulinum Toxin A
por: Kongsaengdao, Subsai, et al.
Publicado: (2021) -
Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study
por: Kongsaengdao, Subsai, et al.
Publicado: (2021) -
Melatonin Receptor Agonists for the Prevention of Delirium: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Maneeton, Benchalak, et al.
Publicado: (2022)